Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry.

Casanova MJ, Chaparro M, Mínguez M, Ricart E, Taxonera C, García-López S, Guardiola J, López-San Román A, Iglesias E, Beltrán B, Sicilia B, Vera MI, Hinojosa J, Riestra S, Domènech E, Calvet X, Pérez-Calle JL, Martín-Arranz MD, Aldeguer X, Rivero M, Monfort D, Barrio J, Esteve M, Márquez L, Lorente R, García-Planella E, de Castro L, Bermejo F, Merino O, Rodríguez-Pérez A, Martínez-Montiel P, Van Domselaar M, Alcaín G, Domínguez-Cajal M, Muñoz C, Gomollón F, Fernández-Salazar L, García-Sepulcre MF, Rodríguez-Lago I, Gutiérrez A, Argüelles-Arias F, Rodriguez C, Rodríguez GE, Bujanda L, Llaó J, Varela P, Ramos L, Huguet JM, Almela P, Romero P, Navarro-Llavat M, Abad Á, Ramírez-de la Piscina P, Lucendo AJ, Sesé E, Madrigal RE, Charro M, García-Herola A, Pajares R, Khorrami S, Gisbert JP.

Inflamm Bowel Dis. 2019 Aug 29. pii: izz192. doi: 10.1093/ibd/izz192. [Epub ahead of print]

PMID:
31504569
2.

EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain.

Chaparro M, Barreiro-de Acosta M, Benítez JM, Cabriada JL, Casanova MJ, Ceballos D, Esteve M, Fernández H, Ginard D, Gomollón F, Lorente R, Nos P, Riestra S, Rivero M, Robledo P, Rodríguez C, Sicilia B, Torrella E, Garre A, García-Esquinas E, Rodríguez-Artalejo F, Gisbert JP; EpidemIBD study group of GETECCU.

Therap Adv Gastroenterol. 2019 May 21;12:1756284819847034. doi: 10.1177/1756284819847034. eCollection 2019.

3.

Clinical characteristics, associated malignancies and management of primary sclerosing cholangitis in inflammatory bowel disease patients: A multicenter retrospective cohort study.

Guerra I, Bujanda L, Castro J, Merino O, Tosca J, Camps B, Gutiérrez A, Gordillo Ábalos J, de Castro L, Iborra M, Carbajo AY, Taxonera C, Rodríguez-Lago I, Mesonero F, de Francisco R, Gómez-Gómez GJ, Chaparro M, Tardillo CA, Rivero M, Algaba A, Martín Arranz E, Cañete F, Vicente R, Sicilia B, Antolín B, Prieto V, Márquez L, Benítez JM, Camo P, Piqueras M, Gargallo CJ, Hinojosa E, Huguet JM, Pérez Calle JL, Van Domselaar M, Rodriguez C, Calvet X, Muñoz-Villafranca C, García-Sepulcre MF, Munoz-Garrido P, Fernández-Clotet A, Gómez Irwin L, Hernández S, Guardiola J, Sempere L, González Muñoza C, Hernández V, Beltrán B, Barrio J, Alba C, Moraleja I, López-Sanromán A, Riestra S, Martínez Montiel P, Garre A, Arranz L, García MJ, Martín Arranz MD, Corsino P, Arias L, Fernández-Salazar L, Fernández-Pordomingo A, Andreu M, Iglesias E, Ber Y, Mena R, Arroyo Villarino MT, Mora M, Ruiz L, López-Serrano P, Blazquez I, Villoria A, Fernández M, Bermejo F, Banales JM, Domènech E, Gisbert JP; Spanish GETECCU group (ENEIDA Project).

J Crohns Colitis. 2019 May 7. pii: jjz094. doi: 10.1093/ecco-jcc/jjz094. [Epub ahead of print]

PMID:
31063540
4.

Effectiveness and Safety of the Switch from Remicade® to CT-P13 in Patients with Inflammatory Bowel Disease.

Chaparro M, Garre A, Guerra Veloz MF, Vázquez Morón JM, De Castro ML, Leo E, Rodriguez E, Carbajo AY, Riestra S, Jiménez I, Calvet X, Bujanda L, Rivero M, Gomollón F, Benítez JM, Bermejo F, Alcaide N, Gutiérrez A, Mañosa M, Iborra M, Lorente R, Rojas-Feria M, Barreiro-de Acosta M, Kolle L, Van Domselaar M, Amo V, Argüelles F, Ramírez E, Morell A, Bernardo D, Gisbert JP.

J Crohns Colitis. 2019 Oct 28;13(11):1380-1386. doi: 10.1093/ecco-jcc/jjz070.

PMID:
30976785
5.

The Harvey-Bradshaw Index Adapted to a Mobile Application Compared with In-Clinic Assessment: The MediCrohn Study.

Echarri A, Vera I, Ollero V, Arajol C, Riestra S, Robledo P, Calvo M, Gallego F, Ceballos D, Castro B, Aguas M, García-López S, Marín-Jiménez I, Chaparro M, Mesonero P, Guerra I, Guardiola J, Nos P, Muñiz J.

Telemed J E Health. 2019 Mar 8. doi: 10.1089/tmj.2018.0264. [Epub ahead of print]

PMID:
30848700
6.

Letter: impact of Epstein-Barr virus serological status on clinical outcomes in adult patients with inflammatory bowel disease - authors' reply.

de Francisco R, Castaño-García A, Riestra S.

Aliment Pharmacol Ther. 2019 Feb;49(4):477-478. doi: 10.1111/apt.15125. No abstract available.

PMID:
30689254
7.

Editorial: which inflammatory bowel disease patients should be screened for Epstein-Barr virus infection? Authors' reply.

de Francisco R, Castaño-García A, Riestra S.

Aliment Pharmacol Ther. 2018 Nov;48(10):1159-1160. doi: 10.1111/apt.15002. No abstract available.

PMID:
30375688
8.

Short and long-term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry.

Chaparro M, Garre A, Ricart E, Iborra M, Mesonero F, Vera I, Riestra S, García-Sánchez V, Luisa De Castro M, Martin-Cardona A, Aldeguer X, Mínguez M, de-Acosta MB, Rivero M, Muñoz F, Andreu M, Bargalló A, González-Muñoza C, Pérez Calle JL, García-Sepulcre MF, Bermejo F, Huguet JM, Cabriada JL, Gutiérrez A, Mañosa M, Villoria A, Carbajo AY, Lorente R, García-López S, Piqueras M, Hinojosa E, Arajol C, Sicilia B, Conesa AM, Sainz E, Almela P, Llaó J, Roncero O, Camo P, Taxonera C, Domselaar MV, Pajares R, Legido J, Madrigal R, Lucendo AJ, Alcaín G, Doménech E, Gisbert JP; GETECCU study group.

Aliment Pharmacol Ther. 2018 Oct;48(8):839-851. doi: 10.1111/apt.14930.

PMID:
30281832
9.

Impact of Epstein-Barr virus serological status on clinical outcomes in adult patients with inflammatory bowel disease.

de Francisco R, Castaño-García A, Martínez-González S, Pérez-Martínez I, González-Huerta AJ, Morais LR, Fernández-García MS, Jiménez S, Díaz-Coto S, Flórez-Díez P, Suárez A, Riestra S.

Aliment Pharmacol Ther. 2018 Oct;48(7):723-730. doi: 10.1111/apt.14933. Epub 2018 Aug 10.

PMID:
30095176
10.

Serial Tuberculin Skin Tests Improve the Detection of Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease.

Taxonera C, Ponferrada Á, Riestra S, Bermejo F, Saro C, Martín-Arranz MD, Cabriada JL, Barreiro-de Acosta M, de Castro ML, López-Serrano P, Barrio J, Suarez C, Iglesias E, Argüelles-Arias F, Ferrer I, Marín-Jiménez I, Hernández-Camba A, Bastida G, Van Domselaar M, Martínez-Montiel P, Olivares D, Rivero M, Fernandez-Salazar L, Nantes Ó, Merino O, Alba C, Gisbert JP; CONVERT study group from GETECCU .

J Crohns Colitis. 2018 Nov 15;12(11):1270-1279. doi: 10.1093/ecco-jcc/jjy104.

PMID:
30052856
11.

Performance of Two Screening Questionnaires for Inflammatory Arthritis in Patients with Inflammatory Bowel Disease.

Queiro R, Rodríguez-Caminero S, Riestra S, de Francisco R, Pérez-Martínez I, Ballina J.

Biomed Res Int. 2018 May 8;2018:8618703. doi: 10.1155/2018/8618703. eCollection 2018.

12.

High rates of tuberculin skin test positivity due to methotrexate therapy: False positive results?

Arias-Guillén M, Sánchez Menéndez MM, Alperi M, Riestra S, González Budiño MT, García-Clemente MM, Martínez-González S, Enríquez AI, Alonso-Arias R, Palacios Gutiérrez JJ, Santibáñez M, Coto-Segura P, Camblor PM, García-Alfonso L, Morante I, Escalante P.

Semin Arthritis Rheum. 2018 Dec;48(3):538-546. doi: 10.1016/j.semarthrit.2018.03.018. Epub 2018 Mar 29.

PMID:
29735171
13.

Pyoderma gangrenosum and primary cutaneous cryptococcosis in an ulcerative colitis patient.

Fraile López M, de Francisco R, Pérez-Martínez I, García García B, Vivanco Allende B, Asensi V, Riestra S.

Gastroenterol Hepatol. 2019 Feb;42(2):107-108. doi: 10.1016/j.gastrohep.2018.01.012. Epub 2018 Mar 5. English, Spanish. No abstract available.

PMID:
29519678
14.

Prevalence of Malnutrition and Nutritional Characteristics of Patients With Inflammatory Bowel Disease.

Casanova MJ, Chaparro M, Molina B, Merino O, Batanero R, Dueñas-Sadornil C, Robledo P, Garcia-Albert AM, Gómez-Sánchez MB, Calvet X, Trallero MDR, Montoro M, Vázquez I, Charro M, Barragán A, Martínez-Cerezo F, Megias-Rangil I, Huguet JM, Marti-Bonmati E, Calvo M, Campderá M, Muñoz-Vicente M, Merchante A, Ávila AD, Serrano-Aguayo P, De Francisco R, Hervías D, Bujanda L, Rodriguez GE, Castro-Laria L, Barreiro-de Acosta M, Van Domselaar M, Ramirez de la Piscina P, Santos-Fernández J, Algaba A, Torra S, Pozzati L, López-Serrano P, Arribas MDR, Rincón ML, Peláez AC, Castro E, García-Herola A, Santander C, Hernández-Alonso M, Martín-Noguerol E, Gómez-Lozano M, Monedero T, Villoria A, Figuerola A, Castaño-García A, Banales JM, Díaz-Hernández L, Argüelles-Arias F, López-Díaz J, Pérez-Martínez I, García-Talavera N, Nuevo-Siguairo OK, Riestra S, Gisbert JP.

J Crohns Colitis. 2017 Dec 4;11(12):1430-1439. doi: 10.1093/ecco-jcc/jjx102.

PMID:
28981652
15.

Modulatory effect of intestinal polyamines and trace amines on the spontaneous phasic contractions of the isolated ileum and colon rings of mice.

Sánchez M, Suárez L, Andrés MT, Flórez BH, Bordallo J, Riestra S, Cantabrana B.

Food Nutr Res. 2017 May 26;61(1):1321948. doi: 10.1080/16546628.2017.1321948. eCollection 2017.

16.

Association between disease activity and quality of life in ulcerative colitis: Results from the CRONICA-UC study.

Panés J, Domènech E, Aguas Peris M, Nos P, Riestra S, Juliá de Páramo B, Cea-Calvo L, Romero C, Marín-Jiménez I.

J Gastroenterol Hepatol. 2017 Nov;32(11):1818-1824. doi: 10.1111/jgh.13795.

PMID:
28370253
17.

Association between psychological measures with inflammatory anddisease-related markers of inflammatory bowel disease.

Abautret-Daly Á, Dempsey E, Riestra S, de Francisco-García R, Parra-Blanco A, Rodrigo L, Medina C, Connor TJ, Harkin A.

Int J Psychiatry Clin Pract. 2017 Sep;21(3):221-230. doi: 10.1080/13651501.2017.1306081. Epub 2017 Mar 29.

PMID:
28353360
18.

Early Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease.

Taxonera C, Ponferrada Á, Bermejo F, Riestra S, Saro C, Martín-Arranz MD, Cabriada JL, Barreiro-de Acosta M, de Castro ML, López-Serrano P, Barrio J, Suarez C, Iglesias E, Argüelles-Arias F, Ferrer I, Marín-Jiménez I, Hernández-Camba A, Bastida G, Van Domselaar M, Martínez-Montiel P, Olivares D, Alba C, Gisbert JP; SEGURTB study group from GETECCU.

J Crohns Colitis. 2017 Jul 1;11(7):792-800. doi: 10.1093/ecco-jcc/jjx022.

PMID:
28333182
19.

Risk factors for tuberculosis in inflammatory bowel disease: anti-tumor necrosis factor and hospitalization.

Riestra S, de Francisco R, Arias-Guillén M, Saro C, García-Alvarado M, Duque JM, Palacios JJ, Muñoz F, Blanco L, Castaño O, Pérez-Martínez I, Martínez-Camblor P, Pérez Hernández D, Suárez A.

Rev Esp Enferm Dig. 2016 Sep;108(9):541-9. doi: 10.17235/reed.2016.4440/2016.

20.

Patient satisfaction in the management of mild-to-moderate ulcerative colitis: Results of a Delphi study among patients and physicians.

Casellas F, Ginard D, Riestra S.

Dig Liver Dis. 2016 Oct;48(10):1172-9. doi: 10.1016/j.dld.2016.06.036. Epub 2016 Jul 14.

PMID:
27474198
21.

Corrigendum: Diagnostic Performance of the Simple Clinical Colitis Activity Index Self-Administered Online at Home by Patients With Ulcerative Colitis: CRONICA-UC Study.

Marín-Jiménez I, Nos P, Domènech E, Riestra S, Gisbert JP, Calvet X, Cortés X, Iglesias E, Huguet JM, Taxonera C, Fernández R, Carpio D, Gutiérrez A, Guardiola J, Laria LC, Sicilia B, Bujanda L, Cea-Calvo L, Romero C, Rincón Ó, Juliá B, Panés J.

Am J Gastroenterol. 2016 Jun;111(6):912. doi: 10.1038/ajg.2016.176. No abstract available.

PMID:
27249998
22.

Diagnostic Performance of the Simple Clinical Colitis Activity Index Self-Administered Online at Home by Patients With Ulcerative Colitis: CRONICA-UC Study.

Marín-Jiménez I, Nos P, Domènech E, Riestra S, Gisbert JP, Calvet X, Cortés X, Iglesias E, Huguet JM, Taxonera C, Fernández R, Carpio D, Gutiérrez A, Guardiola J, Laria LC, Sicilia B, Bujanda L, Cea-Calvo L, Romero C, Rincón Ó, Juliá B, Panés J.

Am J Gastroenterol. 2016 Feb;111(2):261-8. doi: 10.1038/ajg.2015.403. Epub 2016 Jan 12. Erratum in: Am J Gastroenterol. 2016 Jun;111(6):912.

PMID:
26753886
23.

Resources Utilization and Costs the Year Before and After Starting Treatment with Adalimumab in Crohn's Disease Patients.

Saro C, Ceballos D, Muñoz F, De la Coba C, Aguilar MD, Lázaro P, Iglesias-Flores E, Barreiro-de Acosta M, Hernández-Durán MD, Barrio J, Riestra S, Fernández Salazar L; EFICADEC Researchers Group.

Inflamm Bowel Dis. 2015 Jul;21(7):1631-40. doi: 10.1097/MIB.0000000000000413.

PMID:
25961910
24.

Gastroenterology case report of mesalazine-induced cardiopulmonary hypersensitivity.

Ferrusquía J, Pérez-Martínez I, Gómez de la Torre R, Fernández-Almira ML, de Francisco R, Rodrigo L, Riestra S.

World J Gastroenterol. 2015 Apr 7;21(13):4069-77. doi: 10.3748/wjg.v21.i13.4069.

25.

Treatment preferences of patients with Crohn's disease: Development of the IMPLICA questionnaire.

Borruel N, Castro J, Riestra S, Costi M, Casellas F.

Rev Esp Enferm Dig. 2014 Jun;106(6):372-80.

26.

T-cell profiling and the immunodiagnosis of latent tuberculosis infection in patients with inflammatory bowel disease.

Arias-Guillén M, Riestra S, de Francisco R, Palacios JJ, Belda J, Escalante P, Pérez-Martínez I, Molinos LM, Garcia-Clemente M, Pando-Sandoval A, Rodrigo L, Prieto A, Martínez-Camblor P, Losada A, Casan P.

Inflamm Bowel Dis. 2014 Feb;20(2):329-38. doi: 10.1097/01.MIB.0000438429.38423.62.

PMID:
24378597
27.

Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients.

Aguas M, Bastida G, Cerrillo E, Beltrán B, Iborra M, Sánchez-Montes C, Muñoz F, Barrio J, Riestra S, Nos P.

World J Gastroenterol. 2012 Aug 28;18(32):4391-8. doi: 10.3748/wjg.v18.i32.4391.

28.

Mucosal healing restores normal health and quality of life in patients with inflammatory bowel disease.

Casellas F, Barreiro de Acosta M, Iglesias M, Robles V, Nos P, Aguas M, Riestra S, de Francisco R, Papo M, Borruel N.

Eur J Gastroenterol Hepatol. 2012 Jul;24(7):762-9. doi: 10.1097/MEG.0b013e32835414b2.

PMID:
22517240
29.

Case-control study for colorectal cancer genetic susceptibility in EPICOLON: previously identified variants and mucins.

Abulí A, Fernández-Rozadilla C, Alonso-Espinaco V, Muñoz J, Gonzalo V, Bessa X, González D, Clofent J, Cubiella J, Morillas JD, Rigau J, Latorre M, Fernández-Bañares F, Peña E, Riestra S, Payá A, Jover R, Xicola RM, Llor X, Carvajal-Carmona L, Villanueva CM, Moreno V, Piqué JM, Carracedo A, Castells A, Andreu M, Ruiz-Ponte C, Castellví-Bel S; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association.

BMC Cancer. 2011 Aug 5;11:339. doi: 10.1186/1471-2407-11-339.

30.

Kaposi's sarcoma: an opportunistic infection by human herpesvirus-8 in ulcerative colitis.

Rodríguez-Peláez M, Fernández-García MS, Gutiérrez-Corral N, de Francisco R, Riestra S, García-Pravia C, Rodríguez JI, Rodrigo L.

J Crohns Colitis. 2010 Nov;4(5):586-90. doi: 10.1016/j.crohns.2010.03.006. Epub 2010 Apr 20.

PMID:
21122564
31.

Susceptibility genetic variants associated with colorectal cancer risk correlate with cancer phenotype.

Abulí A, Bessa X, González JR, Ruiz-Ponte C, Cáceres A, Muñoz J, Gonzalo V, Balaguer F, Fernández-Rozadilla C, González D, de Castro L, Clofent J, Bujanda L, Cubiella J, Reñé JM, Morillas JD, Lanas A, Rigau J, García AM, Latorre M, Saló J, Fernández Bañares F, Argüello L, Peña E, Vilella A, Riestra S, Carreño R, Paya A, Alenda C, Xicola RM, Doyle BJ, Jover R, Llor X, Carracedo A, Castells A, Castellví-Bel S, Andreu M; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association.

Gastroenterology. 2010 Sep;139(3):788-96, 796.e1-6. doi: 10.1053/j.gastro.2010.05.072. Epub 2010 Jun 2.

PMID:
20638935
32.

[A new judicial criterion on the requirements for research and scientific publications].

Riestra SG, Guzmán MF, Galán IR.

Med Clin (Barc). 2011 Mar 12;136(6):264-6. doi: 10.1016/j.medcli.2010.02.023. Epub 2010 May 11. Spanish. No abstract available.

PMID:
20462606
33.

Duodenal biopsy may be avoided when high transglutaminase antibody titers are present.

Vivas S, Ruiz de Morales JG, Riestra S, Arias L, Fuentes D, Alvarez N, Calleja S, Hernando M, Herrero B, Casqueiro J, Rodrigo L.

World J Gastroenterol. 2009 Oct 14;15(38):4775-80.

34.

[Down's syndrome and celiac disease in the adult: description of a series of nine cases].

Rodrigo L, Fuentes D, Alvarez N, Riestra S.

Med Clin (Barc). 2010 Sep 4;135(7):337-8. doi: 10.1016/j.medcli.2009.06.004. Epub 2009 Aug 6. Spanish. No abstract available.

PMID:
19664788
35.

[Turner's syndrome and adult celiac disease].

Rodrigo L, Fuentes D, Álvarez N, Riestra S.

Med Clin (Barc). 2010 Jun 12;135(2):93-4. doi: 10.1016/j.medcli.2009.04.015. Epub 2009 Jun 10. Spanish. No abstract available.

PMID:
19520392
36.

[Relapsing acute pancreatitis associated with gluten enteropathy. Clinical, laboratory, and evolutive characteristics in thirty-four patients].

Rodrigo L, Alvarez N, Riestra S, de Francisco R, González Bernardo O, García Isidro L, López Vázquez A, López Larrea C.

Rev Esp Enferm Dig. 2008 Dec;100(12):746-51. Spanish.

37.

Higher constitutive IL15R alpha expression and lower IL-15 response threshold in coeliac disease patients.

Bernardo D, Garrote JA, Allegretti Y, León A, Gómez E, Bermejo-Martin JF, Calvo C, Riestra S, Fernández-Salazar L, Blanco-Quirós A, Chirdo F, Arranz E.

Clin Exp Immunol. 2008 Oct;154(1):64-73. doi: 10.1111/j.1365-2249.2008.03743.x.

38.

Factors that impact health-related quality of life in adults with celiac disease: a multicenter study.

Casellas F, Rodrigo L, Vivancos JL, Riestra S, Pantiga C, Baudet JS, Junquera F, Diví VP, Abadia C, Papo M, Gelabert J, Malagelada JR.

World J Gastroenterol. 2008 Jan 7;14(1):46-52.

39.

[Diet and colon cancer].

Rodrigo L, Riestra S.

Rev Esp Enferm Dig. 2007 Apr;99(4):183-9. Review. Spanish. No abstract available.

40.

Sustained improvement of health-related quality of life in Crohn's disease patients treated with infliximab and azathioprine for 4 years.

Casellas F, Rodrigo L, Niño P, Pantiga C, Riestra S, Malagelada JR.

Inflamm Bowel Dis. 2007 Nov;13(11):1395-400.

PMID:
17567874
41.

Is gliadin really safe for non-coeliac individuals? Production of interleukin 15 in biopsy culture from non-coeliac individuals challenged with gliadin peptides.

Bernardo D, Garrote JA, Fernández-Salazar L, Riestra S, Arranz E.

Gut. 2007 Jun;56(6):889-90. No abstract available.

42.

[Increased prevalence of celiac disease in first and second-grade relatives. A report of a family with 19 studied members].

Rodrigo L, Fuentes D, Riestra S, Niño P, Alvarez N, López-Vázquez A, López-Larrea C.

Rev Esp Enferm Dig. 2007 Mar;99(3):149-55. Spanish.

43.

Celiac disease: an old disease with new interesting aspects.

Rodrigo L, Riestra S.

Expert Rev Clin Immunol. 2007 Mar;3(2):103-10. doi: 10.1586/1744666X.3.2.103. No abstract available.

PMID:
20477097
44.

Usefulness of duodenal biopsy during routine upper gastrointestinal endoscopy for diagnosis of celiac disease.

Riestra S, Domínguez F, Fernández-Ruiz E, García-Riesco E, Nieto R, Fernández E, Rodrigo L.

World J Gastroenterol. 2006 Aug 21;12(31):5028-32.

45.

Hepatitis B surface antigen detection using pooled sera. A cost-benefit analysis.

Fernández E, Rodrigo L, García S, Riestra S, Blanco C.

Rev Esp Enferm Dig. 2006 Feb;98(2):112-21. English, Spanish.

46.

Celiac disease (CD), ulcerative colitis (UC), and primary sclerosing cholangitis (PSC) in one patient: a family study.

Cadahía V, Rodrigo L, Fuentes D, Riestra S, de Francisco R, Fernández M.

Rev Esp Enferm Dig. 2005 Dec;97(12):907-13. English, Spanish.

47.

Comparison of six human anti-transglutaminase ELISA-tests in the diagnosis of celiac disease in the Saharawi population.

Fernández E, Riestra S, Rodrigo L, Blanco C, López-Vázquez A, Fuentes D, Moreno M, López-Larrea C.

World J Gastroenterol. 2005 Jun 28;11(24):3762-6.

48.

Use of low concentrations of human IgA anti-tissue transglutaminase to rule out selective IgA deficiency in patients with suspected celiac disease.

Fernández E, Blanco C, García S, Dieguez A, Riestra S, Rodrigo L.

Clin Chem. 2005 Jun;51(6):1014-6. Epub 2005 Mar 24. No abstract available.

49.

Diverse clinical presentations of celiac disease in the same family.

Rodrigo L, Riestra S, Fuentes D, González S, López-Vázquez A, López-Larrea C.

Rev Esp Enferm Dig. 2004 Sep;96(9):612-6; 416-9. English, Spanish.

50.

A population-based study on the incidence of inflammatory bowel disease in Oviedo (Northern Spain).

Rodrigo L, Riestra S, Niño P, Cadahía V, Tojo R, Fuentes D, Moreno M, González Ballina E, Fernández E.

Rev Esp Enferm Dig. 2004 May;96(5):296-305. English, Spanish.

Supplemental Content

Loading ...
Support Center